Description: iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
Home Page: www.intron.co.kr
137, Sagimakgol-ro
Seongnam-si,
South Korea
Phone:
82 3 1739 5678
Officers
| Name | Title |
|---|---|
| Mr. Seong-Jun Yoon | Chief Exec. Officer & Pres |
| Kyung Won Yoon | Chief Exec. Officer & VP - Planning & Management |
| Mr. Sang-Hyun Kang | CTO & VP - R&D Department |
| Jae-Koo Seol | Sr. MD - Production - OS Center/Overseas Department |
| Soo Yun Jun | Director of R&D |
| Ji Sung Park | Exec. Director of Production |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 9.325 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 93 |